REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Mega Mulia Pharma (Indonesia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pt Mega Mulia Pharma Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Pt Mega Mulia Pharma is a company in Indonesia, with a head office in Palembang. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on August 25, 2008. In its most recent financial highlights, the company reported a net sales revenue increase of 10.22% in 2025. Its’ total assets recorded a growth of 11.25%.

Headquarters
Jl. Semangka I No. 11B RT. 033, RW. 011
Palembang; South Sumatra; Postal Code: 30114

Contact Details: Purchase the Pt Mega Mulia Pharma report to view the information.

Basic Information
Registered Capital:
Purchase the Pt Mega Mulia Pharma report to view the information.
Financial Auditors:
Purchase the Pt Mega Mulia Pharma report to view the information.
Incorporation Date:
August 25, 2008
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Mega Mulia Pharma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
10.22%▲
Total Operating Revenue
10.22%▲
Total Assets
11.25%▲

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?